University of California San Francisco

The pharmacokinetic fate of an immunotoxin: HAMA, HARA, ding, ding, dong. (21438824)

Rosenblum M, McLaughlin P PMID: 21438824

PHACE without face? Infantile hemangiomas of the upper body region with minimal or absent facial hemangiomas and associated structural malformations. (21453307)

Nabatian AS, Milgraum SS, Hess CP, Mancini AJ, Krol A, Frieden IJ PMID: 21453307

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. (21436399)

Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, Chawla A, Locksley RM PMID: 21436399

Topical absorption and systemic toxicity. (21425950)

Alikhan FS, Maibach H PMID: 21425950

PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells. (21441599)

Subramanian H, Kashem SW, Collington SJ, Qu H, Lambris JD, Ali H PMID: 21441599

A topical Chinese herbal mixture improves epidermal permeability barrier function in normal murine skin. (21323748)

Man M, Hupe M, Mackenzie D, Kim H, Oda Y, Crumrine D, Lee SH, Martin-Ezquerra G, Trullas C, Mauro TM, Feingold KR, Elias PM, Man MQ PMID: 21323748

Revised minimal baseline series of the International Contact Dermatitis Research Group: evidence-based approach. (21504701)

Alikhan A, Cheng LS, Ale I, Andersen KE, Bruze M, Eun HC, Goh CL, Goossens A, Lachapelle JM, McFadden J, Nixon R, Sasseville D, Maibach HI PMID: 21504701

Basal Cell Carcinoma with a Bonus.

Isabella Fried, Laura B. Pincus, Jeffrey North, Laila El-Shabrawi-Caelen PMID:

Basal Cell Carcinoma with a Bonus.

Isabella Fried, Laura B. Pincus, Jeffrey North, Laila El-Shabrawi-Caelen PMID:

Basal cell carcinoma with a bonus. (21244461)

Fried I, Pincus LB, North J, El-Shabrawi-Caelen L PMID: 21244461